Percutaneous Coronary Intervention Outcomes in Patients With Stable Obstructive Coronary Artery Disease and Myocardial Ischemia-Reference-Cited by-同舟云学术

Percutaneous Coronary Intervention Outcomes in Patients With Stable Obstructive Coronary Artery Disease and Myocardial Ischemia

Published:2014-02-01 Issue:2 Volume:174 Page:232
ISSN:2168-6106
Container-title:JAMA Internal Medicine
language:en
Short-container-title:JAMA Intern Med

Author:

Stergiopoulos Kathleen¹,Boden William E.²,Hartigan Pamela³,Möbius-Winkler Sven⁴,Hambrecht Rainer⁵,Hueb Whady⁶,Hardison Regina M.⁷,Abbott J. Dawn⁸,Brown David L.¹

Affiliation:

1. Division of Cardiovascular Medicine, Department of Medicine, State University of New York–Stony Brook School of Medicine, Stony Brook

2. Samuel S Stratton VA Medical Center, Albany Medical Center, Albany, New York

3. VA Cooperative Studies Program Coordinating Center, VA Connecticut Healthcare System, West Haven

4. Universität Leipzig, Leipzig, Germany

5. Klinikum, Links der Weser GmbH, Chefarzt Klinik für Kardiologie und Angiologie, Bremen, Germany

6. Heart Institute of the University of Sao Paolo, Sao Paolo, Brazil

7. Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania

8. Warren Alpert Brown University School of Medicine, Providence, Rhode Island

Publisher

American Medical Association (AMA)

Subject

Internal Medicine

Cited by 234 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimal medical therapy vs revascularization in chronic coronary syndromes: Does ISCHEMIA move the needle toward or away from revascularization??;Vascular Pharmacology;2024-03

2. Fondamentaux de l’évaluation des thérapeutiques, médicamenteuses et non médicamenteuses – un cadre pour l’évaluation des processus d’autoguérison;Hegel;2024-01-18

3. Machine learning-based prediction of composite risk of cardiovascular events in patients with stable angina pectoris combined with coronary heart disease: development and validation of a clinical prediction model for Chinese patients;Frontiers in Pharmacology;2024-01-10

4. Significant Downplay and Underreporting of Adverse Events in Patients Who Underwent Percutaneous Coronary Intervention of Chronic Total Occlusions;The American Journal of Cardiology;2024-01

5. Serum YKL-40 in coronary heart disease: linkage with inflammatory cytokines, artery stenosis, and optimal cut-off value for estimating major adverse cardiovascular events;Frontiers in Cardiovascular Medicine;2023-10-31